School of Psychological Science, La Trobe University, Melbourne/Bundoora, Victoria, Australia.
Clin Genet. 2009 Nov;76(5):471-6. doi: 10.1111/j.1399-0004.2009.01275.x. Epub 2009 Sep 30.
Fragile X-associated tremor/ataxia syndrome (FXTAS) affects older males carrying premutation, that is, expansions of the CGG repeat (in the 55-200 range), in the FMR1 gene. The neurological changes are linked to the excessive FMR1 messenger RNA (mRNA), becoming toxic through a 'gain-of-function'. Because elevated levels of this mRNA are also found in carriers of the smaller expansion (grey zone) alleles, ranging from 40 to 54 CGGs, we tested for a possible role of these alleles in the origin of movement disorders associated with tremor. We screened 228 Australian males affected with idiopathic Parkinson's disease and other causes of parkinsonism recruited from Victoria and Tasmania for premutation and grey zone alleles. The frequencies of either of these alleles were compared with the frequencies in a population-based sample of 578 Guthrie spots from consecutive Tasmanian male newborns (controls). There was a significant excess of premutation carriers (Fisher's exact test p = 0.006). There was also a more than twofold increase in grey zone carriers in the combined sample of the Victorian and Tasmanian cases, with odds ratio (OR ) = 2.36, and 95% confidence intervals (CI): 1.20-4.63, as well as in Tasmanian cases only (OR = 2.33, 95% CI: 1.06-5.13), compared with controls. The results suggest that the FMR1 grey zone alleles, as well as premutation alleles, might contribute to the aetiology of disorders associated with parkinsonism.
脆性 X 相关震颤/共济失调综合征(FXTAS)影响携带前突变(即 FMR1 基因中 CGG 重复扩展范围在 55-200 之间)的老年男性。神经变化与过多的 FMR1 信使 RNA(mRNA)有关,通过“功能获得”变得有毒。由于在较小扩展(灰色区域)等位基因的携带者中也发现了这种 mRNA 的升高水平,范围从 40 到 54 CGG,我们测试了这些等位基因在与震颤相关的运动障碍起源中的可能作用。我们筛选了 228 名来自维多利亚州和塔斯马尼亚州的患有特发性帕金森病和其他帕金森病原因的澳大利亚男性,以寻找前突变和灰色区域等位基因。将这些等位基因中的任何一种的频率与来自塔斯马尼亚州连续男性新生儿(对照组)的 578 个格思里斑点的基于人群的样本中的频率进行比较。前突变携带者的频率明显过多(Fisher 精确检验 p = 0.006)。在维多利亚州和塔斯马尼亚州病例的组合样本中,灰色区域携带者的增加也超过了两倍,优势比(OR)= 2.36,95%置信区间(CI):1.20-4.63,以及仅在塔斯马尼亚州病例中(OR = 2.33,95%CI:1.06-5.13),与对照组相比。结果表明,FMR1 灰色区域等位基因以及前突变等位基因可能有助于与帕金森病相关的疾病的病因。